Gefticip 250mg Tablet
₹ 2,499.00/-
Free Home Delivery: Available with Cash on Delivery (COD) Services
Buy Gefticip 250mg Tablet Online
Salt: Gefitinib (250mg)
Gefticip Tablet is an effective medication used for the treatment of non-small cell lung cancer (NSCLC). It is prescribed for patients whose cancer has spread to other parts of the body and who possess abnormal epidermal growth factor receptor (EGFR) genes. It is also useful for individuals who have not undergone previous cancer treatments.
The prescribed dose should be followed as per your doctor's advice. Continue the treatment for the duration recommended by your healthcare provider, which will vary based on your specific needs and response to the medicine. Regular liver function tests may be required during the treatment period.
Common Side Effects:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
If you experience any of these side effects, drink plenty of fluids and inform your doctor if any side effects become persistent or severe. If symptoms like mouth ulceration, vision changes, or breathing difficulties occur, it’s important to notify your doctor immediately.
Women undergoing treatment with Gefticip Tablet should use an effective contraception method to avoid pregnancy during the treatment and for one month after the completion of the course.
Uses of Gefticip Tablet
Non-Small Cell Lung Cancer: Gefticip Tablet is used to treat non-small cell lung cancer (NSCLC), particularly in cases where it has spread to other areas of the body. It is effective when used alone or in combination with other medications.
Benefits of Gefticip Tablet
- Helps treat non-small cell lung cancer (NSCLC), a major form of lung cancer affecting both smokers and non-smokers.
- Gefticip Tablet works by inhibiting the abnormal protein that triggers the multiplication of cancer cells, slowing down or halting their spread.
- It is a potent, yet toxic medicine; thus, it is essential to discuss its risks and benefits thoroughly with your doctor.
- Avoid alcohol during treatment and ensure adequate hydration by drinking plenty of water.
Side Effects of Gefticip Tablet
Side effects can occur during the treatment. However, most side effects are temporary and do not require medical intervention. Common side effects include:
- Diarrhea
- Dry mouth
- Nausea and vomiting
- Loss of appetite
- Weakness
- Itchy or cracked skin
- Increased liver enzymes
- Hair loss
- Rash and other skin issues
- Blood in the urine or a burning sensation during urination
- If these side effects persist or worsen, contact your healthcare provider.
How to Use Gefticip Tablet
- Take this medicine exactly as prescribed by your doctor.
- Swallow the tablet whole without chewing, crushing, or breaking it.
- Gefticip Tablet can be taken with or without food, but it’s best to take it at the same time every day to maintain consistency.
- Ensure that antacids are avoided 2 hours before or 1 hour after taking Gefticip Tablet.
- How Gefticip Tablet Works
Gefticip Tablet is an anti-cancer drug that works by targeting and blocking the action of abnormal proteins responsible for signaling cancer cells to proliferate. This action helps prevent or slow the growth of cancer cells in the body.
Safety Advice
- Pregnancy: Gefticip Tablet is not recommended during pregnancy due to potential risks to the developing baby. It may only be prescribed in life-threatening situations when the benefits outweigh the risks.
- Breastfeeding: Gefticip Tablet should not be used during breastfeeding, as it may pass into breast milk and harm the baby.
- Lung Conditions: If you have any existing lung diseases, consult your doctor before starting Gefticip Tablet treatment.
- Liver Conditions: Gefticip Tablet is considered safe for patients with liver disease, though limited data suggests dose adjustment may not be necessary. Always consult your doctor.
- Alcohol: Avoid consuming alcohol during the treatment as it may interact adversely with the medication.
- Driving: Gefticip Tablet can cause side effects that may impair your ability to drive or operate machinery. Exercise caution if you experience fatigue or weakness.
What to Do If You Miss a Dose
If you forget to take a dose of Gefticip Tablet, skip the missed dose and continue your usual schedule. Do not double the dose to make up for a missed one.
Quick Tips for Using Gefticip Tablet
- Gefticip Tablet is effective for treating advanced or metastatic non-small cell lung cancer (NSCLC).
- Take the tablet at the same time each day, either with or without food.
- Avoid using antacids within 2 hours before or 1 hour after taking the tablet.
- If diarrhea occurs, ensure to drink plenty of fluids and inform your doctor if it continues or if blood appears in the stools.
- Women should use a reliable contraceptive method during treatment and for one month afterward to prevent pregnancy.
- Regular monitoring of liver function may be advised by your doctor during treatment.
- Notify your doctor if you experience mouth ulcers, vision changes, shortness of breath, or any breathing difficulties.
Frequently Asked Questions (FAQs)
What are the common side effects of Gefticip Tablet?
Common side effects include diarrhea, nausea, vomiting, loss of appetite, weakness, sore mouth, itchy skin, dry mouth, hair loss, and fever.
Is Gefticip Tablet a targeted therapy?
Yes, Gefticip 250mg Tablet is a targeted drug therapy that helps treat advanced non-small-cell lung cancer (NSCLC).
Who should not use Gefticip Tablet?
Gefticip Tablet is not suitable for children under 18, pregnant or breastfeeding women, or anyone allergic to its components.
Is it safe for women of reproductive potential to use Gefticip Tablet?
Gefticip Tablet is not recommended during pregnancy and breastfeeding. Women who are pregnant, planning to get pregnant, or breastfeeding should inform their healthcare provider before starting the treatment.
What should I avoid while taking Gefticip Tablet?
It is advised to avoid taking antacids or any medication that reduces stomach acid within two hours before or one hour after taking Gefticip 250mg Tablet.
- Product Fact Box
- Molecule Name: Gefitinib
- Therapeutic Class: Antineoplastics
- Pharmacological Class: Tyrosine kinase inhibitors
- Indications: Non-small cell lung cancer (NSCLC)
References
- Accord Healthcare SLU, Electronic Medicines Compendium (emc), Revised on Feb 2021. [Accessed on 01st March 2023]. Medicines.org.uk
- Fresenius Kabi, US Food and Drug Administration, Revised on Dec 2018. [Accessed on 01st March 2023]. FDA
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Treatment of Disorders of Bowel Motility and Water Flux, 12th edition, 2011, 1341.
- KD Tripathi, Essentials of Medical Pharmacology, Antiemetic, Prokinetic, and Digestant Drugs, 7th edition, 2013, 669.
